You are viewing the site in preview mode
Skip to main content
|
Variable
| |
Value
|
|---|
|
Agea
|
Mean ± SD
|
81.8 ± 7.9 (64 to 96)
|
|
Sexb
|
Male
|
18 (37.5%)
|
| |
Female
|
30 (62.5%)
|
|
Eyeb
|
OD
|
25 (47.2%)
|
| |
OS
|
28 (52.8%)
|
|
Lateralityb
|
Unilateral
|
43 (89.6%)
|
| |
Bilateral
|
5 (10.4%)
|
|
DMb
|
Nondiabetic
|
40 (83.3%)
|
| |
Diabetic
|
8 (16.7%)
|
|
Phakic statusb
|
Pseudophakic
|
37 (69.8%)
|
| |
Phakic
|
16 (30.2%)
|
|
Legacyb
|
L-Bevacizumab
|
10 (19.2%)
|
| |
L-Ranibizumab
|
42 (80.8%)
|
- OD right eye, OS left eye, DM diabetes mellitus, L-Bevacizumab Legacy-Bevacizumab, L-Ranibizumab Legacy-Ranibizumab
- aMean ± SD
- bNumber (percentage)
